188 related articles for article (PubMed ID: 19234089)
1. Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.
Yeh CC; Li H; Malhotra D; Huang MC; Zhu BQ; Goetzl EJ; Vessey DA; Karliner JS; Mann MJ
Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1193-9. PubMed ID: 19234089
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
Zhang F; Xia Y; Yan W; Zhang H; Zhou F; Zhao S; Wang W; Zhu D; Xin C; Lee Y; Zhang L; He Y; Gao E; Tao L
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H250-61. PubMed ID: 26589326
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts.
B Gowda S; Gowda D; Kain V; Chiba H; Hui SP; Chalfant CE; Parcha V; Arora P; Halade GV
Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H599-H611. PubMed ID: 34415189
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility.
Li C; Zheng S; You H; Liu X; Lin M; Yang L; Li L
J Hepatol; 2011 Jun; 54(6):1205-13. PubMed ID: 21145832
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
[TBL] [Abstract][Full Text] [Related]
9. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
[TBL] [Abstract][Full Text] [Related]
10. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.
Hadas Y; Vincek AS; Youssef E; Żak MM; Chepurko E; Sultana N; Sharkar MTK; Guo N; Komargodski R; Kurian AA; Kaur K; Magadum A; Fargnoli A; Katz MG; Hossain N; Kenigsberg E; Dubois NC; Schadt E; Hajjar R; Eliyahu E; Zangi L
Circulation; 2020 Mar; 141(11):916-930. PubMed ID: 31992066
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis.
Chen R; Cai X; Liu J; Bai B; Li X
Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841
[TBL] [Abstract][Full Text] [Related]
12. Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.
Yeh CC; Li H; Malhotra D; Turcato S; Nicholas S; Tu R; Zhu BQ; Cha J; Swigart PM; Myagmar BE; Baker AJ; Simpson PC; Mann MJ
J Cell Biochem; 2010 Apr; 109(6):1185-91. PubMed ID: 20186881
[TBL] [Abstract][Full Text] [Related]
13. Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits.
Qin F; Liang MC; Liang CS
Biochim Biophys Acta; 2005 Jun; 1740(3):499-513. PubMed ID: 15949720
[TBL] [Abstract][Full Text] [Related]
14. β
Cannavo A; Rengo G; Liccardo D; Pun A; Gao E; George AJ; Gambino G; Rapacciuolo A; Leosco D; Ibanez B; Ferrara N; Paolocci N; Koch WJ
J Am Coll Cardiol; 2017 Jul; 70(2):182-192. PubMed ID: 28683966
[TBL] [Abstract][Full Text] [Related]
15. S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses.
Means CK; Miyamoto S; Chun J; Brown JH
J Biol Chem; 2008 May; 283(18):11954-63. PubMed ID: 18296752
[TBL] [Abstract][Full Text] [Related]
16. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
17. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
18. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.
Frati A; Ricci B; Pierucci F; Nistri S; Bani D; Meacci E
Mol Endocrinol; 2015 Jan; 29(1):53-67. PubMed ID: 25415609
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.
Karliner JS
J Cardiovasc Pharmacol; 2009 Mar; 53(3):189-97. PubMed ID: 19247197
[TBL] [Abstract][Full Text] [Related]
20. The sphingosine 1-phosphate receptor, S1PR₁, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons.
Chi XX; Nicol GD
J Neurophysiol; 2010 Nov; 104(5):2741-8. PubMed ID: 20844107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
